Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION

Approval Number

SIN13977P

Drug Name

AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION

Product Name

AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION

Approval Date

June 20, 2011

Registrant

APOTHECA MARKETING PTE LTD

Licence Holder

APOTHECA MARKETING PTE LTD

Regulatory Information

Registrant

APOTHECA MARKETING PTE LTD

Licence Holder

APOTHECA MARKETING PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

POWDER, FOR SUSPENSION

Route of Administration

ORAL

Medical Information

ATC Code

J01FA10

ATC Item Name

azithromycin

Manufacturer Information

Pharmaceutical Manufacturer

APOTHECA MARKETING PTE LTD

Manufacturers

KERN PHARMA, S. L.

Active Ingredients

Ingredient Name

AZITHROMYCIN DIHYDRATE 209.62 mg/5 ml EQV AZITHROMYCIN ANHYDROUS

Strength

200 mg/5 ml

Drug MonographAzithromycin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy